⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for advanced malignant pleural mesothelioma

Every month we try and update this database with for advanced malignant pleural mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural MesotheliomaNCT04166734
Advanced Malign...
Pembrolizumab
Stereotactic Bo...
18 Years - Royal Marsden NHS Foundation Trust
A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate ChemotherapyNCT01769547
Advanced Malign...
MPM
Dovitinib
18 Years - Ontario Clinical Oncology Group (OCOG)
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)NCT00128102
Mesothelioma
Lung Cancer
Vorinostat
Placebo
18 Years - Merck Sharp & Dohme LLC
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPMNCT01358084
Advanced Malign...
NGR-hTNF
Placebo
Best Supportive...
18 Years - AGC Biologics S.p.A.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: